Keyword: biotech medicines
News
24.04.2013
- Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...
News
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
News
17.01.2011
- Outgoing ThyssenKrupp finance chief Alan Hippe will take up the same position at Roche Holding, replacing Erich Hunziker as the Swiss drugmaker implements cost cuts after a series...
News
13.01.2011
- Merck & Co struck an alliance with contract researcher Parexel International to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called...
